ACHP Letter to Acting FDA Commissioner on the Accelerated Approval of Drugs and Biologics
ACHP sent a letter to FDA’s Acting Commissioner, Sara Brenner, with comments on the Expedited Program for Serious Conditions.
ACHP sent a letter to FDA’s Acting Commissioner, Sara Brenner, with comments on the Expedited Program for Serious Conditions.
February 26, 2025 The Alliance of Community Health Plans (ACHP) sent a letter to the Energy and Commerce Subcommittee on Health with comments on pharmacy benefit manager (PBM) transparency, encouraging comprehensive reform to bring much-needed relief to patients at the pharmacy counter. The letter was sent ahead of the hearing An Examination of How Reining in PBMs Will … Continued
As the only national payer group to push for comprehensive drug reforms, ACHP believes that it is past time for pharmaceutical companies to answer for their pricing practices.
We are pleased that CMS is anticipating a new risk-adjustment model calibrated on MA encounter data, reflected in our MA for Tomorrow initiative.
ACHP sent a letter to the Trump HHS Transition Team outlining policy priorities for community health plans in 2025